Lipoproteins Modulate Growth and P-glycoprotein Expression in Drug-resistant HER2-overexpressed Breast Cancer Cells

Overview

Journal Heliyon

Specialty Social Sciences

Date 2019 Jun 12

PMID 31183434

Citations 5

Authors

Z S Siti

A M I Seoparjoo

H Shahrul

Affiliations

Soon will be listed here.

Abstract

Background: Drug resistance remains as a challenge in the treatment of HER2-overexpressed breast cancer. Emerging evidence from clinical studies show relation of oxidized low density lipoprotein (LDL) and very low density lipoprotein (VLDL) level with drug resistance. However, the underlying molecular mechanisms for this effect remain unclear. Therefore, the aim of this study was to determine the effects of oxidized-LDL and VLDL in drug-resistant HER2-overexpressed breast cancer cells.

Methods: An cell model for tamoxifen-resistant HER2 overexpressed UACC732 cells was created using the pulse method. Cells were exposed to oxidized LDL (oxLDL) and very low density lipoprotein (VLDL) separately. Effects on cell morphology was studied using phase contrast microscopic changes. Percentage of cell viability was measured using proliferation assay kit. Development of tamoxifen resistance was determined based on P-gp expression with flow cytometry. Further analysis includedcell death measurement with flow cytometry method.

Results: UACC732 cells exposed to VLDL exhibited fibroblast-like morphology. This was further supported by proliferation assay, where the percentage of cell viability achieved more than 100% with 100 μg/ml of VLDL exposure, indicating cell proliferation. Findings also showed that VLDL caused reduction in expression of Pgp in resistant cells compared to resistant cells alone (p = 0.02).

Conclusion: Results of this study suggest that VLDL may play a role in growth of drug-resistant HER2-overexpressing cells. Lower expression of P-gp in presence of VLDL need to be investigated further.

Citing Articles

Hyperlipidemia Increases Nalbuphine Brain Accumulation with Multiple Dosing without Affecting Its Analgesic Response-Its Respiratory Depression Potential Should Be Investigated in Future Studies.

Elsherbiny M, Almukainzi M, Amer E, Emara M Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543067 PMC: 10975284. DOI: 10.3390/ph17030282.

Chemotherapeutic Resistance Genes of Breast Cancer Patients - An Overview.

Ajith A, Subramani S, Manickam A, Ramasamy S Adv Pharm Bull. 2022; 12(4):649-657.

PMID: 36415633 PMC: 9675926. DOI: 10.34172/apb.2022.048.

Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).

Huang J, Lee H Int J Mol Sci. 2022; 23(8).

PMID: 35457118 PMC: 9031540. DOI: 10.3390/ijms23084300.

The significances and clinical implications of cholesterol components in human breast cancer.

Wei Y, Huang Y, Yang W, Huang Q, Chen Y, Zeng K Sci Prog. 2021; 104(3):368504211028395.

PMID: 34510991 PMC: 10450717. DOI: 10.1177/00368504211028395.

Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma.

Salehi S, Mirmiranpour H, Rabizadeh S, Esteghamati A, Tomasello G, Alibakhshi A Oxid Med Cell Longev. 2021; 2021:8864905.

PMID: 34381561 PMC: 8352694. DOI: 10.1155/2021/8864905.

References

Rocejanasaroj A, Tencomnao T, Sangkitikomol W . Thunbergia laurifolia extract minimizes the adverse effects of toxicants by regulating P-glycoprotein activity, CYP450, and lipid metabolism gene expression in HepG2 cells. Genet Mol Res. 2014; 13(1):205-19. DOI: 10.4238/2014.January.10.12. View

Lee J, Kim J, Bae K, Oh M, Kim Y, Kim J . Low-density lipoprotein-mimicking nanoparticles for tumor-targeted theranostic applications. Small. 2014; 11(2):222-31. DOI: 10.1002/smll.201303277. View

Zabirnyk O, Liu W, Khalil S, Sharma A, Phang J . Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis. 2009; 31(3):446-54. PMC: 2832543. DOI: 10.1093/carcin/bgp299. View

. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

Lofterod T, Mortensen E, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T . Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 2018; 18(1):654. PMC: 6003110. DOI: 10.1186/s12885-018-4568-2. View

Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M . Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res. 2014; 58. PMC: 4095759. DOI: 10.3402/fnr.v58.25145. View

Nobili S, Landini I, Mazzei T, Mini E . Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Med Res Rev. 2011; 32(6):1220-62. DOI: 10.1002/med.20239. View

Rodrigues Dos Santos C, Fonseca I, Dias S, Mendes de Almeida J . Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer. 2014; 14:132. PMC: 3942620. DOI: 10.1186/1471-2407-14-132. View

Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S . Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. Biochemistry. 2005; 44(11):4499-509. DOI: 10.1021/bi048669w. View

10.

Vassilev B, Sihto H, Li S, Holtta-Vuori M, Ilola J, Lundin J . Elevated levels of StAR-related lipid transfer protein 3 alter cholesterol balance and adhesiveness of breast cancer cells: potential mechanisms contributing to progression of HER2-positive breast cancers. Am J Pathol. 2015; 185(4):987-1000. DOI: 10.1016/j.ajpath.2014.12.018. View

11.

Lian T, Wang L, Lo Y, Huang I, Wu M . Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochim Biophys Acta. 2008; 1781(10):601-9. DOI: 10.1016/j.bbalip.2008.06.009. View

12.

Nielsen S, Karpe F . Determinants of VLDL-triglycerides production. Curr Opin Lipidol. 2012; 23(4):321-6. DOI: 10.1097/MOL.0b013e3283544956. View

13.

Antalis C, Arnold T, Rasool T, Lee B, Buhman K, Siddiqui R . High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Breast Cancer Res Treat. 2009; 122(3):661-70. DOI: 10.1007/s10549-009-0594-8. View

14.

Suzuki K, Ito Y, Wakai K, Kawado M, Hashimoto S, Toyoshima H . Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. Cancer Epidemiol Biomarkers Prev. 2004; 13(11 Pt 1):1781-7. View

15.

Badid N, Baba Ahmed F, Merzouk H, Belbraouet S, Mokhtari N, Merzouk S . Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res. 2009; 16(2):159-67. DOI: 10.1007/s12253-009-9199-0. View

16.

Nurwidya F, Takahashi F, Murakami A, Takahashi K . Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res Treat. 2012; 44(3):151-6. PMC: 3467417. DOI: 10.4143/crt.2012.44.3.151. View

17.

Tsai Y, Rainey W, Johnson M, Bollag W . VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production. Mol Cell Endocrinol. 2016; 433:138-46. PMC: 4955520. DOI: 10.1016/j.mce.2016.05.018. View

18.

Yue S, Li J, Lee S, Lee H, Shao T, Song B . Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014; 19(3):393-406. PMC: 3969850. DOI: 10.1016/j.cmet.2014.01.019. View

19.

Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey J . Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol. 2006; 24(36):5658-63. DOI: 10.1200/JCO.2006.07.0250. View

20.

Khaidakov M, Mehta J . Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21. PLoS One. 2012; 7(10):e46973. PMC: 3473036. DOI: 10.1371/journal.pone.0046973. View